74 phenotypes from 2 alleles in 2 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Lipatm1c(EUCOMM)Hmgu/Lipatm1c(EUCOMM)Hmgu Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn involves: C57BL/6J * C57BL/6N * C57BL/6NTac	abnormal carbohydrate metabolism	J:270182
	abnormal enzyme/coenzyme activity	J:270182
	abnormal hepatocyte morphology	J:270182
	abnormal lipid oxidation	J:270182
	abnormal tricarboxylic acid cycle	J:270182
	normal adipose tissue phenotype	J:270182
	decreased gonadal fat pad weight	J:270182
	decreased liver triglyceride level	J:270182
	decreased susceptibility to diet-induced obesity	J:270182
	decreased triglyceride lipase activity	J:270182
	decreased unsaturated fatty acids level	J:270182
	enlarged liver	J:270182
	hepatic steatosis	J:270182
	impaired gluconeogenesis	J:270182
	improved glucose tolerance	J:270182
	increased circulating alanine transaminase level	J:270182
	increased circulating aspartate transaminase level	J:270182
	increased circulating cholesterol level	J:270182
	increased circulating ketone body level	J:270182
	increased circulating LDL cholesterol level	J:270182
	increased insulin sensitivity	J:270182
	increased liver cholesterol level	J:270182
	increased liver weight	J:270182
	increased respiratory quotient	J:270182
	increased unsaturated fatty acids level	J:270182
	liver fibrosis	J:270182
	liver inflammation	J:270182
	pale liver	J:270182
Lipatm1Ggb/Lipatm1Ggb involves: 129P2/OlaHsd * CF-1	abnormal adrenal gland morphology	J:49674
	abnormal alveolar macrophage morphology	J:101217
	abnormal brown adipose tissue morphology	J:68812
	abnormal choroid plexus morphology	J:68812
	abnormal duodenum morphology	J:68812
	abnormal hepatocyte morphology	J:49674, J:68812
	abnormal inguinal fat pad morphology	J:68812
	abnormal interscapular fat pad morphology	J:68812
	abnormal intestinal mucosa morphology	J:49674
	abnormal intestine morphology	J:49674
	abnormal jejunum morphology	J:68812
	abnormal Kupffer cell morphology	J:68812
	abnormal lipid level	J:68812
	abnormal liver morphology	J:49674
	abnormal liver sinusoid morphology	J:49674
	abnormal lung morphology	J:68812
	abnormal pulmonary alveolus morphology	J:101217
	abnormal retroperitoneal fat pad morphology	J:68812
	abnormal small intestinal villus morphology	J:68812
	abnormal small intestine morphology	J:68812
	abnormal spleen morphology	J:49674, J:68812
	abnormal type II pneumocyte morphology	J:101217
	abnormal white fat cell size	J:68812
	absent subcutaneous adipose tissue	J:68812
	chronic inflammation	J:101217
	decreased body weight	J:49674
	decreased brown adipose tissue amount	J:68812
	decreased circulating HDL cholesterol level	J:68812
	decreased epididymal fat pad weight	J:68812
	decreased subcutaneous adipose tissue amount	J:68812
	decreased white adipose tissue amount	J:68812
	emphysema	J:101217
	enlarged mesenteric lymph nodes	J:68812
	enlarged spleen	J:68812
	hepatic steatosis	J:68812
	hepatosplenomegaly	J:68812
	increased brown fat cell lipid droplet size	J:68812
	increased circulating free fatty acids level	J:68812
	increased circulating insulin level	J:68812
	increased circulating LDL cholesterol level	J:68812
	increased club cell number	J:101217
	increased food intake	J:68812
	increased liver cholesterol level	J:49674
	increased liver triglyceride level	J:49674
	increased liver weight	J:49674, J:68812
	increased spleen weight	J:49674, J:68812
	increased type II pneumocyte number	J:101217
	insulin resistance	J:68812
	lung inflammation	J:101217
	pale kidney	J:68812
	premature death	J:68812